U.S. markets open in 2 hours 14 minutes
  • S&P Futures

    3,669.00
    +1.75 (+0.05%)
     
  • Dow Futures

    29,866.00
    -2.00 (-0.01%)
     
  • Nasdaq Futures

    12,487.00
    +32.75 (+0.26%)
     
  • Russell 2000 Futures

    1,837.40
    -0.10 (-0.01%)
     
  • Crude Oil

    44.96
    -0.32 (-0.71%)
     
  • Gold

    1,844.80
    +14.60 (+0.80%)
     
  • Silver

    24.33
    +0.25 (+1.02%)
     
  • EUR/USD

    1.2139
    +0.0024 (+0.19%)
     
  • 10-Yr Bond

    0.9480
    0.0000 (0.00%)
     
  • Vix

    20.96
    +0.19 (+0.91%)
     
  • GBP/USD

    1.3445
    +0.0069 (+0.52%)
     
  • USD/JPY

    104.2530
    -0.1710 (-0.16%)
     
  • BTC-USD

    19,338.55
    +389.30 (+2.05%)
     
  • CMC Crypto 200

    380.27
    +15.35 (+4.21%)
     
  • FTSE 100

    6,473.36
    +9.97 (+0.15%)
     
  • Nikkei 225

    26,809.37
    +8.39 (+0.03%)
     

Cardiff Oncology: 3Q Earnings Snapshot

·1 min read

SAN DIEGO (AP) _ Cardiff Oncology, Inc. (CRDF) on Thursday reported a loss of $4.5 million in its third quarter.

On a per-share basis, the San Diego-based company said it had a loss of 19 cents.

The molecular diagnostic company posted revenue of $136,000 in the period.

Cardiff Oncology shares have climbed thirteenfold since the beginning of the year. In the final minutes of trading on Thursday, shares hit $17, climbing ninefold in the last 12 months.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CRDF at https://www.zacks.com/ap/CRDF